This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
EPA | Ann: Appointment of Voluntary Administrator | 01/03/19 | 3 | 309 | |||
|
|||||||
EPA | Ann: Enforcement Proceedings Against Bio-Nexus | 27/02/19 | 0 | 109 | |||
|
|||||||
EPA | Ann: Director Resignation | 19/02/19 | 1 | 155 | |||
|
|||||||
EPA | Ann: Final Director's Interest Notice | 19/02/19 | 0 | 128 | |||
|
|||||||
EPA | Ann: Appendix 4C | 01/02/19 | 0 | 66 | |||
|
|||||||
EPA | Ann: Results of Annual General Meeting | 28/11/18 | 0 | 105 | |||
|
|||||||
EPA | Ann: Issue of Convertible Notes and Appendix 3B | 19:28 | 0 | 112 | |||
|
|||||||
EPA | Ann: Appendix 4C | 31/10/18 | 0 | 95 | |||
|
See All Discussions